Aspen Pharmacare | Sustainability Performance
A multinational pharmaceutical company that manufactures and distributes medications. The portfolio includes a diverse range of prescription and over-the-counter products.
1850
South Africa
5,001 - 10,000 employees
Pharmaceuticals
$1B - 10B in revenue
Not profitable
Submit or report inaccurate dataDownload Company InsightsⓘBy downloading this report, you'll receive the most insightful and detailed analysis of the company's sustainability performance, compared to its peers. It includes key industry trends, carbon and energy intensity, nature impact, social metrics, and an in-depth look at key risks and controversies.
Sustainability Ranking & Industry Benchmark
#7618
Overallⓘ#48
in South Africaⓘ#179
in PharmaceuticalsⓘSustainability Maturity
ⓘSustainability Intent
ⓘOverview
Environmental
Carbon emissionsEnergy consumptionWaste ManagementWater ManagementNature and biodiversitySocial
Diversity and InclusionPay GapsHealth and SafetyExternalitiesGovernance
SDG ImpactFinancial Data
Business performanceCapital & innovationAnalyst projections
Critical
Aligned
Aligned
Intensity
Energy consumption (direct) intensity (MWh /$M)
Water consumption intensity (m³ /$M)
Industry Benchmark
120.1
B/M 65.5
70.5
B/M 121.5
Powered by illuminem and GIST Impact
Controversy level
- Aspen Pharmacare Holdings has faced sustained South African Competition Commission enforcement scrutiny including the 2017 ZAR 5 million excessive pricing penalty over cancer medicines, plus the broader Italian and UK price-gouging investigations and the controversial pre-2017 EU oncology essential medicines pricing disputes.
Sustainability employees
ⓘWe follow the strictest rules to ensure compliance with all the relevant data protection laws, including GDPR. Click here for our Privacy Policy.Total sustainability employees
11+
ⓘThis value represents the estimated number of employees in a company with sustainability-related roles or job titles, as determined by Illuminem using publicly available data.